Domain ID
Concept Class ID
Vocabulary ID
help_outline
Concept ID
Concept code
Validity
Concept
Valid start22-Apr-2025
Valid end22-Apr-2025

Term connections

Relationship	Relates to	Concept id	Vocabulary
Active same_as inactive (SNOMED)	Endocrine therapy	4205257	SNOMED
	Hormone therapy	40310108	SNOMED
	Hormone therapy	40446565	SNOMED
Associated procedure of (SNOMED)	Thyroxine treatment started	4206726	SNOMED
Due to of (SNOMED)	Thrombophilia due to hormone therapy	40484498	SNOMED
Has Module	SNOMED CT core	40642539	SNOMED
Has direct substance (SNOMED)	Hormone	4227006	SNOMED
Has intent (SNOMED)	Therapeutic	4133895	SNOMED
Has method	Administration - action	4044700	SNOMED
Has status	Defined	40642537	SNOMED
Is a	Administration of hormone	4278510	SNOMED
	Drug therapy	4216752	SNOMED
Non-standard to Standard map (OMOP)	Hormone therapy	4061650	SNOMED
Precondition of (SNOMED)	Presence of regression of primary malignant neoplasm of prostate after hormone therapy	37154671	SNOMED
SNOMED category to CPT-4 (OMOP)	Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)	2108678	CPT4
SNOMED to CPT-4 equivalent (OMOP)	Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)	2108678	CPT4
Standard to Non-standard map (OMOP)	Endocrine therapy	3418973	Nebraska Lexicon
	Endocrine therapy	4205257	SNOMED
	HORMONAL THERAPY IN THE TRANSEXUALIZING PROCESS	35704308	SUS
	HORMONIOTHERAPY ADJUVANT TO EXTERNAL RADIOTHERAPY OF PROSTATE ADENOCARCINOMA	35704650	SUS
	HORMONIOTHERAPY OF ADENOCARCINOMA OF ADVANCED PROSTATE - 1ST LINE	35704549	SUS
	HORMONIOTHERAPY OF ADENOCARCINOMA OF ADVANCED PROSTATE - 2ND LINE	35704548	SUS
	HORMONIOTHERAPY OF ADVANCED BREAST CARCINOMA - 2ND LINE	35704575	SUS
	HORMONIOTHERAPY OF ADVANCED BREAST CARCINOMA- 1ST LINE	35704576	SUS
	HORMONIOTHERAPY OF ADVANCED ENDOMETRIC ADENOCARCINOMA	35704545	SUS
	HORMONIOTHERAPY OF BREAST CARCINOMA IN STAGE I	35704629	SUS
	HORMONIOTHERAPY OF BREAST CARCINOMA IN STAGE II	35704633	SUS
	HORMONIOTHERAPY OF BREAST CARCINOMA IN STAGE III	35704632	SUS
	HORMONIOTHERAPY OF BREAST CARCINOMA IN STAGE III (PREVIOUS)	35704624	SUS
	HORMONIOTHERAPY PRIOR TO EXTERNAL RADIOTHERAPY OF PROSTATE ADENOCARCINOMA	35704625	SUS
	Hormone therapy	3098431	Nebraska Lexicon
	Hormone therapy	3138944	Nebraska Lexicon
	Hormone therapy	3348256	Nebraska Lexicon
	Hormone therapy	4061650	SNOMED
	Hormone therapy	40310108	SNOMED
	Hormone therapy	40446565	SNOMED
	Hormone therapy	45462104	Read
	Hormonotherapy	45502085	Read
	PREPARATORY HORMONAL TREATMENT FOR SEXUAL REDESIGNAL SURGERY IN THE TRANSEXUALIZING PROCESS	35704307	SUS
	TREATMENT OF DISORDERS OF OTHER ENDOCRINE GLANDS	35704306	SUS
	TREATMENT OF TIREOID GLAND DISORDERS	35704305	SUS
Subsumes	Ablative hormone therapy	4073635	SNOMED
	Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)	2108678	CPT4
	Administration of prophylactic combined calcium and vitamin D3 preparation	45772994	SNOMED
	Androgen deprivation therapy	44806753	SNOMED
	Androgen deprivation therapy	45768763	SNOMED
	Basal insulin regime	37155318	SNOMED
	Basal-bolus insulin regime	37155319	SNOMED
	Basal-plus preprandial insulin regime	37155321	SNOMED
	Controlled ovarian stimulation	37116303	SNOMED
	Erythropoietin therapy	4283247	SNOMED
	Growth hormone therapy (e.g., protropin, hymatrope) (Deprecated)	40218353	HCPCS
	Hormone manipulation	4206120	SNOMED
	Hormone replacement therapy	4141760	SNOMED
	Initiation of first time insulin therapy	4232713	SNOMED
	Internal iliac artery vasopressin infusion	4127265	SNOMED
	Intramuscular calcitonin therapy	4108714	SNOMED
	Intramuscular hormone therapy	4144145	SNOMED
	Intravenous hydrocortisone therapy	4178549	SNOMED
	Introduction of Hormone into Female Reproductive, Percutaneous Approach	43018340	ICD10PCS
	Introduction of Hormone into Female Reproductive, Via Natural or Artificial Opening	43018343	ICD10PCS
	Introduction of Human B-type Natriuretic Peptide into Central Artery, Open Approach	2786958	ICD10PCS
	Introduction of Human B-type Natriuretic Peptide into Central Artery, Percutaneous Approach	2786986	ICD10PCS
	Introduction of Human B-type Natriuretic Peptide into Central Vein, Open Approach	2786465	ICD10PCS
	Introduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach	2786684	ICD10PCS
	Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach	2786712	ICD10PCS
	Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach	2786930	ICD10PCS
	Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Open Approach	2786215	ICD10PCS
	Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach	2786437	ICD10PCS
	Introduction of Other Hormone into Central Artery, Open Approach	2786959	ICD10PCS
	Introduction of Other Hormone into Central Artery, Percutaneous Approach	2786987	ICD10PCS
	Introduction of Other Hormone into Central Vein, Open Approach	2786466	ICD10PCS
	Introduction of Other Hormone into Central Vein, Percutaneous Approach	2786685	ICD10PCS
	Introduction of Other Hormone into Peripheral Artery, Open Approach	2786713	ICD10PCS
	Introduction of Other Hormone into Peripheral Artery, Percutaneous Approach	2786931	ICD10PCS
	Introduction of Other Hormone into Peripheral Vein, Open Approach	2786216	ICD10PCS
	Introduction of Other Hormone into Peripheral Vein, Percutaneous Approach	2786438	ICD10PCS
	Introduction of Other Hormone into Subcutaneous Tissue, Percutaneous Approach	2786175	ICD10PCS
	Introduction of Vasopressor into Central Artery, Open Approach	2786962	ICD10PCS
	Introduction of Vasopressor into Central Artery, Percutaneous Approach	2786990	ICD10PCS
	Introduction of Vasopressor into Central Vein, Open Approach	2786469	ICD10PCS
	Introduction of Vasopressor into Central Vein, Percutaneous Approach	2786688	ICD10PCS
	Introduction of Vasopressor into Peripheral Artery, Open Approach	2786716	ICD10PCS
	Introduction of Vasopressor into Peripheral Artery, Percutaneous Approach	2786934	ICD10PCS
	Introduction of Vasopressor into Peripheral Vein, Open Approach	2786219	ICD10PCS
	Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach	2786441	ICD10PCS
	Leuprorelin therapy	37110049	SNOMED
	Levothyroxine therapy	37312379	SNOMED
	Neoadjuvant endocrine therapy	608568	SNOMED
	Non-ablative hormone therapy	4072511	SNOMED
	Ovulation induction	4247007	SNOMED
	Parathyroid hormone therapy	45763658	SNOMED
	Patient receiving erythropoiesis-stimulating agents (ESA) therapy (CKD)	2108683	CPT4
	Premixed insulin regime	37155320	SNOMED
	Testosterone cypionate therapy	37110089	SNOMED
	Therapy using erythropoietin receptor agonist	604282	SNOMED
	Thyroid stimulating hormone suppression therapy	44806625	SNOMED
	Thyroid stimulating hormone suppression therapy	45766829	SNOMED
Value_as_concept to non-standard map (OMOP)	Personal history of estrogen therapy	45571403	ICD10CM
	Personal history of estrogen therapy	44833172	ICD9CM

License Agreement

In order to use the SNOMED International SNOMED CT Browser and HemOnc, please accept the following license agreement:

SNOMED INTERNATIONAL SNOMED CT LICENSE AGREEMENT

SNOMED International SNOMED CT Browser includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the SNOMED International. All rights reserved. SNOMED CT® was originally created by the College of American Pathologists.
“SNOMED”, “SNOMED CT” and “SNOMED Clinical Terms” are registered trademarks of the SNOMED International (www.snomed.org)

Use of SNOMED CT in SNOMED International SNOMED CT Browser is governed by the conditions of the following SNOMED CT license issued by SNOMED International:

The meaning of the terms “Affiliate”, or “Data Analysis System”, “Data Creation System”, “Derivative”, “End User”, “Extension”, “Member”, “Non-Member Territory”, “SNOMED CT” and “SNOMED CT Content” are as defined in the SNOMED International Affiliate License Agreement (see on the SNOMED International web site).
Information about Affiliate Licensing is available athttp://www.snomed.org/snomed-ct/get-snomed-ct. Individuals or organizations wishing to register as SNOMED International Affiliates can register at mlds.ihtsdotools.org, subject to acceptance of the Affiliate License Agreement (see on the SNOMED International web site).
The current list of SNOMED International Member Territories can be viewed at www.snomed.org/members. Countries not included in that list are "Non-Member Territories".
End Users, that do not hold an SNOMED International Affiliate License, may access SNOMED CT® using SNOMED International SNOMED CT Browser subject to acceptance of and adherence to the following sub-license limitations:
1. The sub-licensee is only permitted to access SNOMED CT® using this software (or service) for the purpose of exploring and evaluating the terminology.
2. The sub-licensee is not permitted the use of this software as part of a system that constitutes a SNOMED CT "Data Creation System" or "Data Analysis System", as defined in the SNOMED International Affiliate License. This means that the sub-licensee must not use SNOMED International SNOMED CT Browser to add or copy SNOMED CT identifiers into any type of record system, database or document.
3. The sub-licensee is not permitted to translate or modify SNOMED CT Content or Derivatives.
4. The sub-licensee is not permitted to distribute or share SNOMED CT Content or Derivatives.
SNOMED International Affiliates may use SNOMED International SNOMED CT Browser as part of a "Data Creation System" or "Data Analysis System" subject to the following conditions:
1. The SNOMED International Affiliate, using SNOMED International SNOMED CT Browsermust accept full responsibility for any reporting and fees due for use or deployment of such a system in a Non-Member Territory.
2. The SNOMED International Affiliate must not useSNOMED International SNOMED CT Browser to access or interact with SNOMED CT in any way that is not permitted by the Affiliate License Agreement.
3. In the event of termination of the Affiliate License Agreement, the use ofSNOMED International SNOMED CT Browser will be subject to the End User limitations noted in 4.

HemOnc license agreement

The HemOnc Vocabulary is a derivative product of HemOnc.org, which is wholly owned and operated by HemOnc.org LLC. Use of the HemOnc Vocabulary is governed by the conditions of this License Agreement issued by HemOnc.org LLC:

The meaning of the terms “Data Analysis System”, “Data Creation System”, and “License” is defined below.
If you are already holding a HemOnc ontology License, you are subject to the terms and conditions of the License for the version of the HemOnc Vocabulary which was provided to you. If you wish to obtain this version of the HemOnc Vocabulary, you are subject to the following limitations.
If you currently do not hold a HemOnc ontology License, you may access the HemOnc Vocabulary subject to acceptance of and adherence to the following limitations:
1. You are permitted to access HemOnc using this software for the purpose of exploring and evaluating the terminology.
2. You are permitted to use HemOnc as part of a system that constitutes a Data Analysis System, as defined below.
3. You are not permitted the use of HemOnc as part of a system that constitutes a Data Creation System, as defined below. This means that you must not use HemOnc identifiers in any type of system intended for direct or indirect patient care.
4. If you share the Licensed Material with a third party, attribution of the HemOnc vocabulary must be given to HemOnc.org LLC, with a URI or hyperlink to HemOnc.org provided if reasonably possible. Use of HemOnc by a third party would be limited to a Data Analysis System and a copy of this License Agreement must be supplied to the third party.
5. You may not use HemOnc as a substitute for formal medical training, substitute it for independent clinical judgment, and construe it as offering medical advice.

If you wish to utilize the vocabulary for purposes other than specified here, contact us by emailing licensing@hemonc.org.

You agree to indemnify and hold HemOnc.org LLC and all parties who have contributed to HemOnc.org and this derivative product harmless from and against all claims, liability, losses, damages, costs, and expenses, including--but not limited to--legal fees

Definitions

Data Analysis System: a computer system that is used to analyze records or other data, but not if that system is also a Data Creation System

Data Creation System: a computer system that is used to create records or other data that is encoded using HemOnc, for the purposes of facilitating patient care

License: the separate CC BY-NC-SA 4.0 license to the full HemOnc ontology

Details

Term connections

Athena – OHDSI Vocabularies Repository

License Agreement

SNOMED INTERNATIONAL SNOMED CT LICENSE AGREEMENT

HemOnc license agreement